Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

The global gene therapy market size was valued at USD 6.30 billion in 2024 and is projected to reach from USD 7.47 billion in ...

Samuel recreated this phenomenon in a lab to prove that it occurs during actual plasmid transfer between bacteria. “We used plasmids that confer antibiotic resistance and introduced them into bacteria ...

2.5 Establishment of BCoV CRISPR/Cas13a assay combined RT-RAA The BCoV-Cas13a assays combined RT-RAA reaction and LwCas13a trans-cleavage system containing T7 transcription were established. For ...

“CLIC has already established an academic manufacturing network for a CD19 CAR-T, with centralised plasmid and vector production ... results from gene-editing technologies such as TALEN and ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...

Abcam’s new CRISPR-Cas9 knockout (KO) cell lines provide reproducible, single gene KOs that support the interrogation of the relationship between genotype and phenotype.

This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...

Southwest United Graduate School, Yunnan Key Laboratory of Cell Metabolism and Diseases, State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan Center for Life Sciences, ...